To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

Post Category: Awareness

June 14, 2024
Sore Mouth and Throat During Cancer Treatment

Description of foods and medications that alleviate symptoms of sore mouth and throat following chemotherapy.

Read More
June 14, 2024
Personalizing Cancer Treatment with 3D Predict™

Kiyatec's 3D Predict™ test uses cells taken from your own tumor and grows these cells in a special environment that mimics what’s happening with your tumor and immune system.

Read More
May 28, 2024
What is ZAP-X® to Treat Brain Cancer?

ZAP-X® looks to set new standards in surgical robotics, radiosurgical safety and efficacy, as well as patient comfort in the treatment of brain cancer.

Read More
May 21, 2024
Announcing 2024’s National HOPE Award Recipient

We are proud to present the 2024 National HOPE Award to Patrick "Paddy" O'Donnell!

Read More
May 16, 2024
WA State Brain Tumor Awareness Day

May 18th, 2024 proclaimed as Brain Tumor Awareness Day in Washington State.

Read More
April 1, 2024
Advancing Hope: The Mission of the Ivy Brain Tumor Center

The Ivy Brain Tumor Center recognizes the profound impact of brain cancer, a disease for which effective treatments remain elusive. Their mission is to instill hope in patients grappling with this condition by spearheading research and development initiatives aimed at discovering and delivering much-needed medications. Despite the discontinuation of large-scale funding for brain cancer research […]

Read More
February 22, 2024
New Website for PCNS Lymphoma

New dedicated website for the Prospect primary central nervous system lymphoma study.

Read More
November 21, 2023
A Grateful November: Celebrating Family Caregivers

In the spirit of Thanksgiving, November becomes a canvas for expressions of gratitude. It's a time to spotlight the often-overlooked heroes among us—family caregivers. These remarkable individuals selflessly carry emotional, physical, and financial responsibilities to safeguard their loved ones on challenging health journeys. Let's take a moment to honor and celebrate these caregivers who give […]

Read More
November 16, 2023
 IGV-001 Phase 2b Clinical Trial

Imvax is conducting a clinical trial to assess the safety and efficacy of IGV-001, an autologous biologic-device combination product in GBM patients.

Read More
October 2, 2023
Oncoheroes Gains FDA Approval for Pediatric Cancer Drug Trials

In a groundbreaking development for pediatric oncology, Oncoheroes Biosciences, Inc. has received the FDA's green light to proceed with two crucial clinical trials. This milestone opens the door to exploring potential drug treatments for young cancer patients, offering newfound hope in the fight against childhood cancer. The U.S. Food and Drug Administration (FDA) recently granted […]

Read More
September 6, 2023
More Great News For The Fight Against GBM! DCVax

Northwest Biotherapeutics has applied for approval to market DCVax®, a personalized immune therapy, for the treatment of Glioblastoma.

Read More
August 14, 2023
Ask for Gleolan Before Brain Tumor Resection

Gleolan is an optical imaging agent indicated in patients with glioma as an adjunct for the visualization of malignant tissue during surgery.

Read More
1 2 3 4


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram